Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

DISRUPT PAD III Observational Study

ClinicalTrials.gov ID: NCT05881421

Public ClinicalTrials.gov record NCT05881421. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective Multi-Center, Post-Market, Observational Study (OS) of the Shockwave Medical, Inc. Intravascular Lithotripsy System in Peripheral Arteries

Study identification

NCT ID
NCT05881421
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Shockwave Medical, Inc.
Industry
Enrollment
1,373 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 15, 2017
Primary completion
Jun 9, 2021
Completion
Jun 9, 2021
Last update posted
May 30, 2023

2017 – 2021

United States locations

U.S. sites
26
U.S. states
21
U.S. cities
25
Facility City State ZIP Site status
Stanford Hospital Palo Alto California 94304
Rocky Mountain Regional VA Medical Center Aurora Colorado 80045
UCHealth Northern Colorado Loveland Colorado 80538
Medstar Washington Hospital Center Washington D.C. District of Columbia 20010
Tallahassee Research Institute Inc. Tallahassee Florida 32308
Piedmont Heart Institute Atlanta Georgia 30309
Northeast Georgia Medical Center Gainesville Georgia 30501
Alexian Brothers Medical Center Elk Grove Village Illinois 60007
Midwest Cardiovascular Research Foundation Davenport Iowa 52803
Steward St. Elizabeth's Medical Center Brighton Massachusetts 02135
St. Joseph Mercy Oakland Pontiac Michigan 48341
North Mississippi Medical Center Tupelo Mississippi 38801
St. Luke's Cardiovascular Consultants Kansas City Missouri 64111
Mount Sinai West New York New York 10019
Columbia University Medical Center New York New York 10032
NC Heart & Vascular Research, LLC Raleigh North Carolina 27607
Ohio Health Research Institute Columbus Ohio 43214
St. John Clinic Bartlesville Oklahoma 74006
Providence Heart & Vascular Institute Portland Oregon 97225
Bryn Mawr Hospital Bryn Mawr Pennsylvania 19010
Pinnacle Health Cardiovascular Institute Harrisburg Pennsylvania 17101
The Miriam Hospital Providence Rhode Island 02906
Baptist Medical Center Memphis Tennessee 38120
St. David's Heart and Vascular (Austin Heart) Austin Texas 78756
Baylor Clinic McNair Campus Houston Texas 77030
Charleston Area Medical Center Charleston West Virginia 25304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05881421, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 30, 2023 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05881421 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →